PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.04%
R&D growth while TRVN reduces spending. John Neff would investigate strategic advantage.
21.61%
G&A growth while TRVN reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.65%
Operating expenses growth while TRVN reduces costs. John Neff would investigate differences.
22.65%
Total costs growth while TRVN reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
3.49%
D&A growth while TRVN reduces D&A. John Neff would investigate differences.
-23.08%
EBITDA decline while TRVN shows 11.47% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-22.65%
Operating income decline while TRVN shows 10.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-58.12%
Other expenses reduction while TRVN shows 292.00% growth. Joel Greenblatt would examine advantage.
-23.20%
Pre-tax income decline while TRVN shows 11.17% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-23.20%
Net income decline while TRVN shows 11.17% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-16.67%
EPS decline while TRVN shows 14.37% growth. Joel Greenblatt would examine position.
-22.50%
Diluted EPS decline while TRVN shows 10.78% growth. Joel Greenblatt would examine position.
5.52%
Share count reduction below 50% of TRVN's 3.82%. Michael Burry would check for concerns.
0.56%
Diluted share increase while TRVN reduces shares. John Neff would investigate differences.